Evidence map›Paper›PMID 25636538›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology

MMP generated matrikines.

J Michael Wells, Amit Gaggar, J Edwin Blalock

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06152718 (New Regenerative and Anti-aging Medicine Approach Based on Single Strand Alpha-1 Collagen for Neo-collagenesis Induction), which is not on this map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06152718 nacompletednot on this map

New Regenerative and Anti-aging Medicine Approach Based on Single Strand Alpha-1 Collagen for Neo-collagenesis Induction: Clinical and Instrumental Experience of a New Medical Device for Dermal Regeneration (Karisma)

TypeinterventionalSponsorUniversity of PalermoRan2023 to 2024Enrolled100ConditionsSkin ManifestationsArmsKarisma
3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 245 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. CCR1Frontiers in immunology · 2026
    Article
  9. Review
  10. Review
  11. X-Ray Exposure Induces Structural Changes in Human Breast Proteins.International journal of molecular sciences · 2025
    Article
  12. Article
  13. Review
  14. Hypolipidemic effect and mechanism of Hedan tablet based on network pharmacology.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J Michael WellsDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham (UAB), USA; UAB Lung Health Center, USA; Department of Medicine, Birmingham VA Medical Center, USA. Electronic address: jmwells@uab.edu.
Amit GaggarDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham (UAB), USA; UAB Lung Health Center, USA; Department of Medicine, Birmingham VA Medical Center, USA.
J Edwin BlalockDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham (UAB), USA; UAB Lung Health Center, USA.
University of Alabama at Birmingham · USBirmingham VA Medical Center · US

Funding

A Novel Proteolytic System of Pulmonary InflammationR01HL102371 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2021
$3.3M
HL-A New Pathway for Neutrophil-induced Airway InflammationR01HL077783 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2006 to 2016
$3.2M
Acquired LTA4H Dysfunction in COPDR01HL110950 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2012 to 2015
$2.0M
PGP, A Possible Biomarker for COPD Exacerbations and or ProgressionR01HL114439 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BLALOCK, J EDWIN · 2012 to 2015
$1.5M
The Role of PGP in COPD-associated Pulmonary HypertensionK08HL123940 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WELLS, JAMES MICHAEL · 2014 to 2018
$744k
NHLBI NIH HHS K08 HL123940NHLBI NIH HHS R01 HL077783NHLBI NIH HHS R01 HL102371NHLBI NIH HHS R01 HL110950NHLBI NIH HHS R01 HL114439
6 · The paper itself

Abstract

Matrikines originate from the fragmentation of extracellular matrix proteins and regulate cellular activities by interacting with specific receptors. Matrikines are implicated in inflammation, immune responses, organ development, wound repair, angiogenesis, atherosclerosis, tumor progression and metastasis due to their ability to alter cellular migration, chemotaxis, and mitogenesis. Matrix metalloproteinases (MMPs) degrade extracellular matrix components under normal circumstances and in disease processes. Of the 20 MMPs identified, MMP-1, MMP-2, MMP-8, MMP-9, and MMP-12 have been implicated in regulating the matrikines Val-Gly-Val-Ala-Pro-Gly (elastin peptide) and proline-glycine-proline (PGP). Elastin peptide fragments are generated by elastolytic enzymes and have implications in atherosclerosis, neovascularization, chronic obstructive pulmonary disease, skin disease, as well as tumor invasion and spread. PGP is produced through a multistep pathway that liberates the tripeptide fragment from extracellular collagen. PGP is best described for its role in neutrophil chemotaxis and is implicated in the pathogenesis of corneal ulcers and in chronic lung conditions. In chronic cigarette smoke related lung disease, the PGP pathway can become a self-propagating cycle of inflammation through cigarette-smoke mediated inhibition of leukotriene A4 hydrolase, the enzyme responsible for degrading PGP and halting acute inflammation. This review highlights the roles of MMPs in generating these important matrikines.

Indexed as

AnimalsExtracellular Matrix ProteinsInflammationMatrix MetalloproteinasesOligopeptidesPeptidesExtracellular Matrix ProteinsMatrix MetalloproteinasesOligopeptidesPeptidesvalyl-alanyl-prolyl-glycineCOPDElastinMatrix metalloproteinaseProline–glycine–proline

Identifiers

PMID25636538
PMCPMC4838901
OpenAlexW2035683946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.